r.mwangi
TL2 Moderator · Ghent
Contributes reviews on supplier material. Based in Ghent.
Joined 3 September 2025 · last posted 1d
86 posts, newest first. Showing up to 150.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #133 · Evidence › Journal club · 26 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Private prescribing in the UK: what is actually involved Replied, post #76 · Regional › UK & Ireland · 26 Jul 2026 · 0 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #12 · Devices › Syringes & needles · 20 Jul 2026 · 0 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Tracking a shortage from primary sources rather than rumour Replied, post #107 · Access › Shortages · 17 Jul 2026 · 11 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Common supplements people ask about, assessed one at a time Replied, post #49 · Practice › Interactions · 15 Jul 2026 · 23 likes On post #45 — agreed on the reasoning, with one qualification. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
-
Follow-up: Reading an interaction checker output critically Replied, post #26 · Practice › Interactions · 1 Jul 2026 · 16 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #89 · Evidence › Journal club · 17 Jun 2026 · 25 likes I read post #87 twice before replying, because I had assumed the opposite. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney…
-
Racemisation and why it is invisible to a mass measurement Replied, post #98 · Analytics › Impurities & related substances · 14 Jun 2026 · 20 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #17 · Start Here › Welcome · 11 Jun 2026 · 2 likes Worth separating two things that post #13 runs together. On the reading order question specifically: start with the how-to-ask materials in this category, then read the…
-
An appeal that succeeded, with the letter structure Replied, post #6 · Access › Insurance & coverage · 31 May 2026 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Prescription portability between countries Replied, post #47 · Access › International · 29 May 2026 · 4 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #35 · Practice › Storage & stability · 20 May 2026 · 0 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Reading a trial's population section before its results Replied, post #31 · Evidence › Trials · 18 May 2026 · 23 likes Coming back to post #29, because the follow-up matters more than the original answer. Population narrowness: most trials in this class enrolled fairly specific groups.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #43 · Practice › Reconstitution · 12 May 2026 · 15 likes On post #39 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #15 · Compounds › Oral incretins · 8 May 2026 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #13 · Analytics › COA interpretation · 30 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #101 · Practice › Dosing & titration · 29 Apr 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
CJC-1295 with and without DAC: what the modification does Replied, post #44 · Compounds › Secretagogues & GH axis · 28 Apr 2026 · 26 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Journal club: is percentage weight change the right endpoint? Replied, post #95 · Evidence › Journal club · 23 Apr 2026 · 2 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #97 · Sourcing › Vendor reports · 21 Apr 2026 · 20 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Citation sweep results: how many references did not say what was claimed Replied, post #78 · Meta › Wiki maintenance · 15 Apr 2026 · 2 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
List price versus negotiated price versus what you pay Replied, post #44 · Access › Pricing · 11 Apr 2026 · 7 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #37 · Evidence › Trials · 8 Apr 2026 · 28 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #11 · Devices › Syringes & needles · 5 Apr 2026 · 5 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Choosing which test to pay for, given a fixed budget Replied, post #55 · Sourcing › Independent verification · 5 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #15 · Clinical › Bloodwork · 25 Mar 2026 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #121 · Access › Pricing · 20 Mar 2026 · 0 likes Picking up post #118: that is the part I would want checked first. Biosimilars and future generics: as patents expire, biosimilar and generic versions might become…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #62 · Compounds › Repair & healing peptides · 14 Mar 2026 · 11 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Personal import allowances, compared — a second dataset Replied, post #83 · Access › International · 11 Mar 2026 · 18 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Contributing data without breaching anyone's privacy Replied, post #60 · Data & Tools › Datasets · 6 Mar 2026 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #37 · Research Methods › N-of-1 designs · 28 Feb 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Forced degradation studies: designing one that is informative Replied, post #12 · Analytics › Method validation · 26 Feb 2026 · 22 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Measurement error in a self-reported exposure Replied, post #17 · Evidence › Study critique · 22 Feb 2026 · 24 likes On post #13 — agreed on the reasoning, with one qualification. Publication bias: a single published positive trial is weaker evidence than multiple published trials…
-
Second pass at: Submitting a sample: the process end to end Replied, post #9 · Sourcing › Independent verification · 20 Feb 2026 · 1 like On post #5 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #16 · Compounds › Tirzepatide · 15 Feb 2026 · 3 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #25 · Outcomes › Body composition · 9 Feb 2026 · 18 likes post #24 is right about the mechanism and I think understates the practical bit. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from…
-
Why this community will not facilitate a group purchase Started this topic · Sourcing › Payments · 7 Feb 2026 · 0 likes Asking directly, because I could not find a straight answer: Why this community will not facilitate a group purchase A logistics question, since the answers here are…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #18 · Analytics › Mass spectrometry · 26 Jan 2026 · 6 likes This follows post #15 rather than contradicting it. Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #54 · Documentation › Wiki requests · 25 Jan 2026 · 29 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
-
Aggregates and why a purity assay may miss them entirely Replied, post #45 · Analytics › Impurities & related substances · 2 Jan 2026 · 11 likes Coming back to post #43, because the follow-up matters more than the original answer. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds…
-
The decimal-point error, and the habit that catches it Replied, post #85 · Practice › Reconstitution · 17 Dec 2025 · 2 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Filter needles: when they help and what they cost you Replied, post #4 · Devices › Syringes & needles · 13 Dec 2025 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #32 · Analytics › Method validation · 11 Dec 2025 · 23 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Prescription requirements and telehealth models Replied, post #55 · Sourcing › Regulatory · 8 Dec 2025 · 1 like post #54 is right about the mechanism and I think understates the practical bit. Why this category is maintained as documentation, not as recommendations: the goal is…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #7 · Compounds › Retatrutide · 18 Nov 2025 · 1 like Worth separating two things that post #3 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #121 · Safety › Adverse events · 11 Nov 2025 · 0 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
-
Tracking that stops updating and then resumes Replied, post #37 · Sourcing › Logistics · 18 Oct 2025 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What pooling buys you and what it destroys Replied, post #40 · Evidence › Meta-analyses · 11 Oct 2025 · 13 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #5 · marked as the solution · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #13 · Evidence › Journal club · 19 Sep 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #57 · Practice › Dosing & titration · 13 Sep 2025 · 2 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Follow-up: Why appetite effects are mostly central Replied, post #35 · Pharmacology › Receptor biology · 7 Sep 2025 · 18 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #23 · Start Here › Welcome · 8 Aug 2025 · 12 likes On post #19 — agreed on the reasoning, with one qualification. The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated.…
-
How to research a compound with no human data without deceiving yourself Replied, post #36 · Compounds › Other compounds · 31 Jul 2025 · 15 likes This follows post #33 rather than contradicting it. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #87 · Compounds › Semaglutide · 26 Jul 2025 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #16 · Compounds › Retatrutide · 19 Jul 2025 · 2 likes Picking up post #13: that is the part I would want checked first. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #53 · Sourcing › Regulatory · 18 Jul 2025 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #63 · Compounds › Oral incretins · 13 Jul 2025 · 0 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #4 · Compounds › Semaglutide · 23 Jun 2025 · 0 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Needle changes between doses on a reusable pen Replied, post #12 · Devices › Pens & autoinjectors · 3 Jun 2025 · 15 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Pre-registering a personal experiment, seriously Replied, post #38 · Research Methods › N-of-1 designs · 29 May 2025 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #5 · Data & Tools › Calculators · 16 May 2025 · 22 likes Coming back to post #3, because the follow-up matters more than the original answer. Reconstitution calculator: enter vial mass, final volume target, and the calculator…
-
A well-designed study with a badly written abstract Replied, post #84 · Evidence › Study critique · 15 May 2025 · 0 likes Coming back to post #82, because the follow-up matters more than the original answer. What makes a methodological criticism substantive: it identifies a specific…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #13 · Compounds › Repair & healing peptides · 13 May 2025 · 31 likes This follows post #10 rather than contradicting it. For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of…
-
Units, standards, and other things that quietly hold the world together Replied, post #38 · Lounge › Off topic · 6 May 2025 · 20 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #50 · Data & Tools › Calculators · 5 May 2025 · 9 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Requesting a page: what makes a good request Replied, post #64 · Documentation › Wiki requests · 20 Apr 2025 · 23 likes This follows post #61 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #22 · Evidence › Journal club · 18 Apr 2025 · 0 likes Worth separating two things that post #18 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
A supplier that answers analytical questions with restated claims Replied, post #51 · Sourcing › Red flags · 4 Apr 2025 · 0 likes On post #47 — agreed on the reasoning, with one qualification. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating…
-
A certificate with no method stated: what can you conclude? Replied, post #16 · Analytics › COA interpretation · 1 Apr 2025 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #30 · Practice › Reconstitution · 12 Mar 2025 · 8 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #36 · Analytics › COA interpretation · 28 Feb 2025 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #8 · Clinical › Comorbidities · 13 Feb 2025 · 26 likes Worth separating two things that post #4 runs together. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #41 · Access › International · 12 Feb 2025 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Fixed versus detachable needles: the trade-offs Replied, post #108 · Devices › Syringes & needles · 12 Jan 2025 · 2 likes Picking up post #105: that is the part I would want checked first. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #56 · Sourcing › Regulatory · 3 Jan 2025 · 9 likes Picking up post #53: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
[2026 update] New subcategory: rationale and scope Replied, post #35 · Meta › Announcements · 1 Dec 2024 · 20 likes post #34 answers the question as asked. The question underneath it is different. Notifications: watching this subcategory means you receive notifications when…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #25 · Clinical › Special populations · 23 Nov 2024 · 1 like post #24 answers the question as asked. The question underneath it is different. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of…
-
Washout with a one-week half-life: the arithmetic Replied, post #7 · Research Methods › N-of-1 designs · 22 Nov 2024 · 2 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #8 · Compounds › Oral incretins · 30 Oct 2024 · 24 likes Picking up post #5: that is the part I would want checked first. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #58 · Analytics › Method validation · 24 Oct 2024 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
US compounding rules and how they changed Replied, post #17 · Regional › North America · 9 Oct 2024 · 1 like Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #4 · Sourcing › Red flags · 7 Oct 2024 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Inability to trace lots: if you ask "where was this synthesised, by whom, under…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #62 · Clinical › Bloodwork · 28 Sep 2024 · 19 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Converting between mg/mL and units per dose, both directions Replied, post #19 · Practice › Reconstitution · 14 Sep 2024 · 2 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
How to ask for a dose change without antagonising anyone Replied, post #17 · Clinical › Prescriber conversations · 22 Aug 2024 · 7 likes post #16 answers the question as asked. The question underneath it is different. What to bring: copies of relevant lab results, pharmacy records (to confirm doses…